![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Dorota Torzecka Jolanta Narbutt Joanna Sysa-jedrzejowska Anna Borowiec Maciej Ptasinska Anetta Woszczek Grzegorz L. Kowalski Marek
Publisher: Informa Healthcare
ISSN: 1466-1861
Source: Mediators of Inflammation, Vol.12, Iss.5, 2003-10, pp. : 303-307
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tumour necrosis factor‐α antagonists as therapies for vitiligo
BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tumour necrosis factor‐α antagonists as therapies for vitiligo
BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Association of tumour necrosis factor‐α polymorphism in patients with end stage renal disease
NEPHROLOGY, Vol. 20, Iss. 6, 2015-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HZ risk associated with TNF‐α in RA
INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. :